Cargando…

The Efficacy and Safety of Enoxaparin: A Meta-analysis

The efficacy and safety of enoxaparin (ENOX) in percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) remains unaddressed. The primary endpoint evaluated was myocardial infarction (MI) or death. The secondary endpoint was defined as major bleeding complications. Stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hai-long, Wang, Xiao-hua, Pang, Jian-jun, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2018
Materias:	Regular Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132125/ https://www.ncbi.nlm.nih.gov/pubmed/30211318 http://dx.doi.org/10.1515/med-2018-0054

Ejemplares similares

Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis
por: Jacobson, Barry, et al.
Publicado: (2019)

Comparison of the Efficacy and Safety of Rivaroxaban and Enoxaparin as Thromboprophylaxis Agents for Orthopedic Surgery—Systematic Review and Meta-Analysis
por: Rinaldi, Ikhwan, et al.
Publicado: (2022)

Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis
por: Silvain, Johanne, et al.
Publicado: (2012)

Comparison of efficiency and safety of rivaroxaban, apixaban and enoxaparin for thromboprophylaxis after arthroplastic surgery: a meta-analysis
por: Yu, Zhi, et al.
Publicado: (2018)

Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total knee arthroplasty: A meta-analysis
por: Huang, Hai-Feng, et al.
Publicado: (2018)

Efficacy and safety of enoxaparin as deep vein thrombosis prophylaxis in critically ill patients
por: Al-Hubail, R, et al.
Publicado: (2012)

Update on the safety and bioequivalence of biosimilars – focus on enoxaparin
por: Jeske, Walter, et al.
Publicado: (2013)

Efficacy and Safety of Enoxaparin for Preventing Venous Thromboembolic Events following Urologic Laparoscopic Surgery
por: Nomura, Takeo, et al.
Publicado: (2013)

Enoxaparin sodium: Lack of efficacy: case report
Publicado: (2020)

Enoxaparin-sodium: Lack of efficacy: case report
Publicado: (2020)

Enoxaparin sodium: Lack of efficacy: case report
Publicado: (2021)

Enoxaparin sodium: Lack of efficacy: case report
Publicado: (2021)

Enoxaparin sodium: Lack of efficacy: case report
Publicado: (2021)

Enoxaparin-sodium: Lack of efficacy: case report
Publicado: (2022)

Enoxaparin-sodium: Lack of efficacy: case report
Publicado: (2021)

Enoxaparin-sodium: Lack of efficacy: case report
Publicado: (2021)

Enoxaparin-sodium: Lack of efficacy : case report
Publicado: (2022)

Clinical efficacy and safety of tripterygium glycosides in treatment of stage IV diabetic nephropathy: A meta-analysis
por: Hong, Yan, et al.
Publicado: (2016)

Comparison of the Efficacy and Safety of Aspirin and Rivaroxaban Following Enoxaparin Treatment for Prevention of Venous Thromboembolism after Hip Fracture Surgery
por: Huang, Qiang, et al.
Publicado: (2019)

Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban
por: Zhao, Xin, et al.
Publicado: (2016)

Safety of Enoxaparin as Venous Thromboembolism Prophylaxis After Rhytidectomy
por: Lisiecki, Jeffrey L., et al.
Publicado: (2019)

Efficacy and Safety of Enoxaparin versus New Oral Anticoagulants to Prevent Venous Thromboembolism after Total Hip Replacement: A Systematic Review and Meta-Analysis
por: Alfarhan, Mohammed Farhan A
Publicado: (2022)

Alteplase/enoxaparin-sodium: Lack of efficacy: case report
Publicado: (2021)

Apixaban/enoxaparin sodium: Lack of efficacy: case report
Publicado: (2021)

Enoxaparin-sodium/heparin: Lack-of-efficacy: case report
Publicado: (2022)

Antiplatelets/enoxaparin sodium/epinephrine: Lack of efficacy: case report
Publicado: (2021)

Aspirin/enoxaparin-sodium/heparin: Lack of efficacy: case report
Publicado: (2021)

Enoxaparin-sodium/remdesivir/steroids: Lack of efficacy: case report
Publicado: (2022)

Fondaparinux vs. enoxaparin for the prevention of venous thromboembolism after total hip replacement: A meta-analysis
por: Dong, Wen-Jun, et al.
Publicado: (2016)

Efficacy and Safety of Two Different Enoxaparin Doses for Thromboprophylaxis in Non-critically Ill Patients: A Randomized Controlled Trial
por: Alavi-Darazam, Ilad, et al.
Publicado: (2022)

Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile
por: Clemens, Andreas, et al.
Publicado: (2012)

Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity
por: Amin, Alpesh, et al.
Publicado: (2023)

Choosing between Enoxaparin and Fondaparinux for the management of patients with acute coronary syndrome: A systematic review and meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials
por: Rosencher, Nadia, et al.
Publicado: (2012)

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
por: Inchiosa, Mario A., et al.
Publicado: (2012)

Rivaroxaban versus enoxaparin for the prevention of recurrent venous thromboembolism in patients with cancer: A meta-analysis
por: Xing, Jiali, et al.
Publicado: (2018)

Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V
por: Fuji, Takeshi, et al.
Publicado: (2015)

Utilizing enoxaparin in the management of STEMI
por: Rubboli, Andrea, et al.
Publicado: (2007)

Enoxaparin-Induced DRESS Syndrome
por: Ronceray, Sophie, et al.
Publicado: (2012)

Enoxaparin-Induced Skin Necrosis
por: Coelho, James, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pp5aetr4d0k8iam1629u071bmn